J1741
J1741 – Injection, ibuprofen, 100 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 2 NDCs crosswalked per 100 MG $3.252/unit ASP+6%
📋 J1741 summary
J1741 is a HCPCS Level II J-code used to bill ibuprofen, 100 mg, billed per 100 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1741: Caldolor
Code J1741
Billing unit 100 MG Payment limit $3.252/unit NDC-Crosswalk 2
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1741
DescriptorInjection, ibuprofen, 100 mg
Billing unit100 MG
Payment limit / unit$3.252
Est. ASP / unit$3.068 est.
Mapped NDCs2
Data periodQ3 2026
Last updated2026-08-20
💊 About Ibuprofen DRUG GUIDE
Oral ibuprofen products (tablets, coated tablets, and liquid-filled capsules) are used to temporarily relieve minor aches and pains from headache, backache, toothache, muscular aches, menstrual cramps, minor arthritis pain, and the common cold, and to temporarily reduce fever.
The oral prescription tablet (Ibu) is also indicated for the signs and symptoms of rheumatoid arthritis and osteoarthritis, mild to moderate pain, and primary dysmenorrhea (painful periods).Caldolor, an intravenous (IV) form, is approved for adults and children 3 months and older to manage mild to moderate pain, to manage moderate to severe pain alongside opioid pain medicines, and to reduce fever.
A separate intravenous solution, Ibuprofen Lysine, is used specifically in premature infants to close a patent ductus arteriosus (PDA) — an abnormal blood vessel connection near the heart — when standard medical management has not worked.
Clinical overview from our editorial drug guide for Ibuprofen. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$3.252
Est. ASP / unit
$3.068 est.
Est. after 2% sequester
$3.187
HCPCS dosage
100 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, ibuprofen, 100 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2013-01-01
Date added2013-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1741 = 100 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1741 WITH EST. MEDICARE PAY
2 NDCs map to J1741. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($3.252/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 66220-0284-22 | Caldolor ibuprofen 800 mg/200mL INJECTION | Cumberland | 20 BAG in 1 CASE (66220-284-22) / 200 mL... | 800 mg/200mL | 160 | $520.32 | — | ● Active | CMS ASP |
| 66220-0287-08 | Caldolor ibuprofen 800 mg/8mL INJECTION | Cumberland | 25 VIAL in 1 CARTON (66220-287-08) / 8 mL... | 800 mg/8mL | 200 | $650.40 | — | ● Active | CMS ASP |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2025 (Q1-Q4)
Total Part B spend
$490.39
Claims
34
Beneficiaries
27
Spend / beneficiary
$18.16
Spend / claim
$14.42
Where J1741 ranks among Part B drugs · 2025 (Q1-Q4) · neighbors ±5
Total spending — #896 of 918
#891
PROGESTERONE J2675
$639.25
#892
VASOPRESSIN* J2598
$589.66
#893
NALOXONE HCL(J2310) J2310
$550.85
#894
PARICALCITOL* J2501
$545.05
#895
ARIXTRA* J1652
$502.49
#896
CALDOLOR J1741
$490.39
#897
FLUCONAZOLE-NACL J1450
$477.33
#898
HALOPERIDOL LACTATE J1630
$472.83
#899
CHLORPROMAZINE HCL J3230
$462.84
#900
EPINEPHRINE J0166
$417.15
#901
DROPERIDOL J1790
$396.42
Total claims — #870 of 918
#865
YCANTH J7354
37
#866
CLOFARABINE* J9027
35
#867
OXLUMO J0224
34
#868
CINRYZE J0598
34
#869
DAPTOMYCIN-0.9% NACL J0874
34
#870
CALDOLOR J1741
34
#871
YESINTEK Q5100
34
#872
RYLAZE J9021
33
#873
HEPAGAM B(J1571) J1571
32
#874
GAMMAGRAFT** Q4111
32
#875
TERBUTALINE SULFATE J3105
30
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (1)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2025 (Q1-Q4) | $490.39 | 27 | 34 | $18.16 | $14.42 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$462.67
Medicare paid
$333.88
Submitted services
554
Denial rate
68.6%
Allowed / service
$2.66
Submitted charges
$11.4K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk
2 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2025
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1741 billing FAQ
What is HCPCS code J1741?
J1741 is a HCPCS Level II J-code used to bill Injection, ibuprofen, 100 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J1741?
One unit of J1741 represents 100 MG. Report the number of units equal to the dose administered divided by 100 MG.
How many units of J1741 should I bill?
Divide the dose administered by the code's unit size (100 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J1741?
The Medicare Part B payment limit is $3.252 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $3.187 per unit. Payment limits are revised quarterly.
Which NDCs bill under J1741?
2 NDCs currently map to J1741 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1741 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.